| EPE309 | Synergizing Health Interventions for Toronto GBMSM (SHIFT): clinicians' and community workers' perspectives on task shifting HIV prevention services in Toronto, Canada | E-poster | Evidence on task sharing |
| EPC236 | Syphilis among pre-exposure prophylaxis initiators in selected districts of Nepal | E-poster | Integrating STI, sexual and reproductive health and HBV and HCV services in HIV prevention programmes |
| EPC080 | Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years' evidence summary | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| EPE107 | Systems analysis and improvement approach for hypertension for people living with HIV | E-poster | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
| EPE146 | TAFU Community intervention model, the magic bullet to reaching the last child living with HIV in communities, a case of Kyenjojo District | E-poster | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| EPC371 | Tailoring HIVST to local communities can improve uptake: lessons learned from a virtual HIV self-testing intervention in India | E-poster | HIV self-testing |
| PESUE18 | Take home dose of Methadone: new arena for OST adherence during COVID-19 in Bangladesh | Poster exhibition | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| EPD546 | Taking the HIV response into the digital ecosystem of young people | E-poster | Social and behavioural aspects and approaches to COVID-19 |
| EPE109 | Talking about treatment-as-prevention and U=U: patient needs and health worker perspectives | E-poster | Strategies to enhance U=U communication and implementation |
| EPB172 | Targeted delivery of dolutegravir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |